The treatment of advanced bladder cancer with methotrexate.
The treatment of advanced bladder cancer with methotrexate.
复制标题
甲氨蝶呤治疗晚期膀胱癌。
DOI：
10.1111/j.1464-410x.1977.tb04551.x
复制
发表时间：
1977
期刊：
影响因子：
--
通讯作者：
H. Bloom
中科院分区：
文献类型：
--
作者：
A. G. Turner;W. Hendry;G. Williams;H. Bloom
61 patients with advanced bladder cancer were treated with methotrexate. 3 different regimes were used, 2 given on an out-patient and 1 on an in-patient basis. A response rate of 56% was found in patients who received 100 mg of methotrexate intravenously every 2 weeks as an out-patient. Provided that renal function is checked before therapy and is normal, then methotrexate can be used safely; it being well tolerated and having few serious side-effects.
